1. Home
  2. NEPH vs LUNG Comparison

NEPH vs LUNG Comparison

Compare NEPH & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • LUNG
  • Stock Information
  • Founded
  • NEPH 1997
  • LUNG 1995
  • Country
  • NEPH United States
  • LUNG United States
  • Employees
  • NEPH N/A
  • LUNG N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • LUNG Industrial Specialties
  • Sector
  • NEPH Health Care
  • LUNG Health Care
  • Exchange
  • NEPH Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • NEPH 60.4M
  • LUNG 63.6M
  • IPO Year
  • NEPH 2004
  • LUNG 2020
  • Fundamental
  • Price
  • NEPH $4.37
  • LUNG $1.52
  • Analyst Decision
  • NEPH Strong Buy
  • LUNG Buy
  • Analyst Count
  • NEPH 2
  • LUNG 7
  • Target Price
  • NEPH $5.50
  • LUNG $6.81
  • AVG Volume (30 Days)
  • NEPH 70.3K
  • LUNG 6.9M
  • Earning Date
  • NEPH 11-06-2025
  • LUNG 11-12-2025
  • Dividend Yield
  • NEPH N/A
  • LUNG N/A
  • EPS Growth
  • NEPH N/A
  • LUNG N/A
  • EPS
  • NEPH 0.14
  • LUNG N/A
  • Revenue
  • NEPH $17,930,000.00
  • LUNG $91,664,000.00
  • Revenue This Year
  • NEPH $24.38
  • LUNG $10.41
  • Revenue Next Year
  • NEPH $10.16
  • LUNG $10.98
  • P/E Ratio
  • NEPH $31.69
  • LUNG N/A
  • Revenue Growth
  • NEPH 32.36
  • LUNG 15.59
  • 52 Week Low
  • NEPH $1.39
  • LUNG $1.47
  • 52 Week High
  • NEPH $5.98
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 42.66
  • LUNG 41.72
  • Support Level
  • NEPH $3.66
  • LUNG $1.65
  • Resistance Level
  • NEPH $4.72
  • LUNG $2.11
  • Average True Range (ATR)
  • NEPH 0.55
  • LUNG 0.25
  • MACD
  • NEPH -0.14
  • LUNG -0.02
  • Stochastic Oscillator
  • NEPH 35.93
  • LUNG 2.47

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: